Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
5.43
-0.09 (-1.63%)
At close: Jun 16, 2025, 3:59 PM
5.55
2.18%
After-hours: Jun 16, 2025, 06:32 PM EDT
-1.63% (1D)
| Bid | 5.25 |
| Market Cap | 484.04M |
| Revenue (ttm) | -1.27M |
| Net Income (ttm) | -218.86M |
| EPS (ttm) | -3.1 |
| PE Ratio (ttm) | -1.75 |
| Forward PE | -4.1 |
| Analyst | Buy |
| Ask | 6 |
| Volume | 851,517 |
| Avg. Volume (20D) | 901,561 |
| Open | 5.60 |
| Previous Close | 5.52 |
| Day's Range | 5.37 - 5.63 |
| 52-Week Range | 1.57 - 7.27 |
| Beta | -0.59 |
About AMLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+4.73%
Amylyx Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
7 months ago
+11.34%
Amylyx Pharmaceuticals shares are trading higher after Baird upgraded the stock from Neutral to Outperform and raised its price target from $3 to $11.
